ライフサイエンスコーパス: acute respiratory failure

1 anical ventilation via endotracheal tube for acute respiratory failure.

2 ulminant disease characterized by sepsis and acute respiratory failure.

3 -saving technique increasingly used to treat acute respiratory failure.

4 U) may improve the outcomes of patients with acute respiratory failure.

5 ng immunocompromised patients with hypoxemic acute respiratory failure.

6 weaning unit, or who had a tracheostomy for acute respiratory failure.

7 CEI/ARB use could predict the development of acute respiratory failure.

8 eroxia, are frequently used in patients with acute respiratory failure.

9 nt to its use in prevention and treatment of acute respiratory failure.

10 al ventilation has already failed to reverse acute respiratory failure.

11 acial mask (oronasal mask) failed to reverse acute respiratory failure.

12 om a Saudi Arabian businessman who died from acute respiratory failure.

13 n it may become the first-line treatment for acute respiratory failure.

14 mbrane oxygenation (ECMO) as a treatment for acute respiratory failure.

15 l ages with coronavirus disease 2019 related acute respiratory failure.

16 ow recommended as a definitive treatment for acute respiratory failure.

17 ll-energy enteral nutrition in patients with acute respiratory failure.

18 redisposing condition in patients developing acute respiratory failure.

19 n the context of other salvage therapies for acute respiratory failure.

20 mortality compared with other etiologies of acute respiratory failure.

21 c target for the prevention and treatment of acute respiratory failure.

22 cal outcomes in critically ill patients with acute respiratory failure.

23 sary immobilization throughout the course of acute respiratory failure.

24 an important role in managing patients with acute respiratory failure.

25 cal outcomes in morbidly obese patients with acute respiratory failure.

26 ewed English-language literature on NPPV for acute respiratory failure.

27 Immunocompromised patients with hypoxemic acute respiratory failure.

28 ces in the care of infants and children with acute respiratory failure.

29 heostomy in critically injured patients with acute respiratory failure.

30 ranspulmonary pressure (PL) in patients with acute respiratory failure.

31 Four of 5 patients died with acute respiratory failure.

32 ventilated woman with status asthmaticus and acute respiratory failure.

33 of 60-year-old medical patients treated for acute respiratory failure.

34 ated than the oronasal mask in patients with acute respiratory failure.

35 ce of oronasal vs. nasal mask ventilation in acute respiratory failure.

36 dant complications in selected patients with acute respiratory failure.

37 ronic obstructive pulmonary disease who have acute respiratory failure.

38 actively breathing ventilated patients with acute respiratory failure.

39 new tools in the management of patients with acute respiratory failure.

40 ular performance accurately in patients with acute respiratory failure.

41 of respiratory failure and the cause of the acute respiratory failure.

42 dollars per year for tracheostomy-related to acute respiratory failure.

43 oxide (NO) reduces pulmonary hypertension in acute respiratory failure.

44 first 24 h after endotracheal intubation for acute respiratory failure.

45 ty is often important in the pathogenesis of acute respiratory failure.

46 improves outcome in pediatric patients with acute respiratory failure.

47 and substantial inflammation, all leading to acute respiratory failure.

48 as the underlying cause(s) of each patient's acute respiratory failure.

49 reliably predict the development of post-HCT acute respiratory failure.

50 Critical illness and PICU treatment for acute respiratory failure.

51 val is used to treat patients suffering from acute respiratory failure.

52 lated patients (223 females, 256 males) with acute respiratory failure.

53 resource use were common among children with acute respiratory failure.

54 of ICU admission for patients with sepsis or acute respiratory failure.

55 indicated in patients with severe refractory acute respiratory failure.

56 , interstitial and airspace inflammation, or acute respiratory failure.

57 urvival benefits in unselected patients with acute respiratory failure.

58 tracorporeal membrane oxygenation for severe acute respiratory failure.

59 ion of only previously healthy children with acute respiratory failure.

60 ion is used to sustain life in patients with acute respiratory failure.

61 d on extracorporeal membrane oxygenation for acute respiratory failure.

62 ory effort in adult patients recovering from acute respiratory failure.

63 nnulae are used in adults with or at risk of acute respiratory failure.

64 ning unit, or 3) received a tracheostomy for acute respiratory failure.

65 ll immunocompromised patients with hypoxemic acute respiratory failure.

66 f sedation during mechanical ventilation for acute respiratory failure.

67 g a diverse group of intubated patients with acute respiratory failure.

68 ll immunocompromised patients with hypoxemic acute respiratory failure.

69 tially more useful predictor of mortality in acute respiratory failure.

70 xternal hospitals were de novo listed during acute respiratory failure.

71 ren were treated at our center with ECLS for acute respiratory failure 36 (73%) survived.

72 4%-6.3%), cardiogenic shock (0.5%-1.5%), and acute respiratory failure (4.3%-20.8%) from 2001 through

73 ive acute respiratory failure) or to prevent acute respiratory failure (5.3% vs 8.3%; risk ratio=0.64

74 ICU admission was mostly required for acute respiratory failure (62.5%) and/or shock (42.3%).

75 The main indications for ICU admission were acute respiratory failure (89%) and shock (53%).

76 all admissions (n = 524; 50%) were marked by acute respiratory failure, acute kidney injury, or sepsi

77 tracorporeal life support was utilized in 36 acute respiratory failure adult patients with a variety

78 entilation in patients who develop hypoxemic acute respiratory failure after abdominal surgery.

79 model to identify those at increased risk of acute respiratory failure after HCT.

80 These results are relevant to acute respiratory failure after initiation of antibiotic

81 Patients with acute respiratory failure after prolonged neutropenia co

82 Noncardiogenic acute respiratory failure among black Americans increase

83 cal trial of extracorporeal life support for acute respiratory failure and (2) the use of extracorpor

84 PATIENTS/Critically ill obese patients with acute respiratory failure and anesthetized swine.

85 Adults with acute respiratory failure and at least 24 hours of invas

86 performed surgical procedures in adults with acute respiratory failure and identifies a patient cohor

87 erminant of patient outcomes after surviving acute respiratory failure and may be present for months,

88 e death occurred in a 59-year-old woman with acute respiratory failure and mean pulmonary artery pres

89 ruitment and derecruitment of atelectasis in acute respiratory failure and might harm brain tissue in

90 erral thoracic center for severe hypercapnic acute respiratory failure and persistent bilateral chest

91 erral thoracic center for severe hypercapnic acute respiratory failure and persistent bilateral chest

92 NPPV is successful in reversing acute respiratory failure and preventing hospital mortal

93 evere microscopic polyangiitis can result in acute respiratory failure and renal failure and is commo

94 rk to examine its applicability to trials of acute respiratory failure and severe sepsis.

95 cal ventilation lasting 24 hours or more for acute respiratory failure and surviving hospitalization.

96 American pediatric intensive care units with acute respiratory failure and suspected influenza virus

97 ive mechanical ventilation failed to reverse acute respiratory failure and, therefore, switched to to

98 endocrine tumour, tumour lysis syndrome, and acute respiratory failure) and three (1%) of 354 patient

99 ary disease/asthma exacerbation, septicemia, acute respiratory failure, and acute renal failure were

100 s were attributed to treatment (pneumonitis, acute respiratory failure, and cardiovascular failure).

101 os pertaining to treatment of severe sepsis, acute respiratory failure, and general critical care int

102 ltifactorial) origin of acute renal failure, acute respiratory failure, and lower serum urea nitrogen

103 Acute kidney injury, acute respiratory failure, and new-onset subclinical atr

104 Advanced age, acute respiratory failure, and sepsis were the strongest

105 with sepsis, organ dysfunction (hypotension, acute respiratory failure, and/or acute renal injury), a

106 undergo invasive mechanical ventilation for acute respiratory failure annually, with unknown long-te

107 ry complications ranging from atelectasis to acute respiratory failure are common causes of poor peri

108 Diaphragmatic weakness and acute respiratory failure are common in sepsis.

109 and ethnic minority patients with sepsis and acute respiratory failure (ARF) experience worse outcome

110 tted to intensive care unit (ICU) because of acute respiratory failure (ARF) has not been determined

111 l care (UMC) in the therapy of patients with acute respiratory failure (ARF) in a prospective, random

112 oreal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rap

113 Acute respiratory failure (ARF) is common in patients wi

114 Notwithstanding, patients with acute respiratory failure (ARF) may be treated with high

115 Acute respiratory failure (ARF) requiring mechanical ven

116 Over 50% of Acute Respiratory Failure (ARF) survivors experience cog

117 RATIONALE: Research evaluating acute respiratory failure (ARF) survivors' outcomes afte

118 RDS (pARDS) in children, is a severe form of acute respiratory failure (ARF).

119 piratory support therapies for patients with acute respiratory failure (ARF).

120 Of the 747 patients (447 with acute respiratory failure [ARF]), 21.3% had a virus dete

121 rome (ARDS) is a common clinical syndrome of acute respiratory failure as a result of diffuse lung in

122 is proposed for treatment for postoperative acute respiratory failure as an alternative to invasive

123 ed noninvasive ventilation or intubation for acute respiratory failure, as compared with 34 (17.0%) a

124 t predictors of mortality with postoperative acute respiratory failure associated with improved survi

125 ck and white patients admitted for sepsis or acute respiratory failure at 27 hospitals.

126 I, 1.9-11.3; OR, 6.7; 95% CI, 2.1-21.1), and acute respiratory failure (beta coefficient, 6.2; 95% CI

127 predicting outcomes for patients with severe acute respiratory failure but do not predict whether ECM

128 (NPPV) is increasingly used in patients with acute respiratory failure, but few data exist regarding

129 Hyperoxia is frequently used for treating acute respiratory failure, but it can cause acute lung i

130 is increasingly applied to prevent or treat acute respiratory failure, but its benefit on survival i

131 tion and analgesic therapy for NPPV to treat acute respiratory failure, but practices vary widely wit

132 otential to improve ventilator management in acute respiratory failure by providing more direct asses

133 Acute respiratory failure, by central and peripheral mec

134 The use of NPPV for patients with acute respiratory failure can be classified into three c

135 Acute respiratory failure can cause profound hypoxaemia

136 in the diagnostic approach to patients with acute respiratory failure, circulatory shock, or cardiac

137 at greater risk of developing noncardiogenic acute respiratory failure compared to white Americans.

138 xtubation respiratory failure; patients with acute respiratory failure due to asthma exacerbations, p

139 atients requiring mechanical ventilation for acute respiratory failure due to COVID-19 compared with

140 dary outcomes included time to recovery from acute respiratory failure, duration of weaning from mech

141 itted to the participating institutions with acute respiratory failure during 1991 were included.

142 Acute kidney injury and acute respiratory failure each occurred in 30% of admiss

143 patients admitted to the ICU with hypoxemic acute respiratory failure, early noninvasive ventilation

144 In patients in acute respiratory failure, elevated esophageal pressures

145 admission including etiology and severity of acute respiratory failure enable to identify patients at

146 Acute respiratory failure etiologies were mostly pneumon

147 st common, were included when they developed acute respiratory failure (failure of a spontaneous brea

148 In patients in hypercapnic acute respiratory failure, for whom escalation to intuba

149 Six presented with acute respiratory failure, four requiring mechanical ven

150 with extracorporeal membrane oxygenation for acute respiratory failure from 1993 to 2007.

151 mmatory events in the airways at the time of acute respiratory failure from acute severe asthma are p

152 cting successful extubation in children with acute respiratory failure from lower respiratory tract d

153 In children with acute respiratory failure from lower respiratory tract d

154 mined ICU use and outcomes for patients with acute respiratory failure from PCP from 1995 to 1997.

155 rtality, whereas patients with postoperative acute respiratory failure had the best survival rate.

156 Patients with interstitial lung disease and acute respiratory failure have a poor prognosis especial

157 illatory ventilation (HFOV) in children with acute respiratory failure have not been established.

158 Children recovering from acute respiratory failure have ongoing healthcare resour

159 In immunocompromised patients with hypoxemic acute respiratory failure, high-flow nasal oxygen when c

160 The main reason for ICU admission was acute respiratory failure in 111 patients (81.6%), of wh

161 Data were recorded on 137 episodes of acute respiratory failure in 131 DNI patients.

162 d with multiple organ dysfunction, including acute respiratory failure in 40% (n = 461).

163 Severe acute respiratory failure in adults causes high mortalit

164 al trials of extracorporeal life support for acute respiratory failure in adults in the 1970s and 199

165 Recent studies in the treatment of acute respiratory failure in children have been targeted

166 frequency oscillatory ventilation (HFOV) for acute respiratory failure in children is prevalent despi

167 Acute respiratory failure in hematological patients is r

168 ith increasing frequency in the treatment of acute respiratory failure in pediatric patients.

169 Acute respiratory failure in term and near term infants

170 r had a preoperative history of pneumonia or acute respiratory failure in the 90 days preceding surge

171 rest in the control group and one episode of acute respiratory failure in the closed-loop group), bot

172 to 17-year-olds mechanically ventilated for acute respiratory failure in the RESTORE (Randomized Eva

173 The incidence of noncardiogenic acute respiratory failure in the United States increased

174 ine trends in the race-specific incidence of acute respiratory failure in the United States.

175 character of mobility for ICU patients with acute respiratory failure in U.S.

176 ion of mechanically ventilated patients with acute respiratory failure; in this regard, pulmonary ult

177 PICU hospitalization for acute respiratory failure, including invasive mechanical

178 ical vignettes of patients hospitalized with acute respiratory failure, including their presenting sy

179 e Americans, the incidence of noncardiogenic acute respiratory failure increased from 31.2 (95% confi

180 Annual cases of noncardiogenic acute respiratory failure increased from 86,755 in 1992

181 In immunocompromised patients with acute respiratory failure, invasive mechanical ventilati

182 Acute respiratory failure is a common reason for admissi

183 Acute respiratory failure is a frequent complication of

184 g and prevent complications in patients with acute respiratory failure is actively debated, with many

185 arly HFOV compared with CMV in children with acute respiratory failure is associated with worse outco

186 ife support in the management of adults with acute respiratory failure is being redefined by advances

187 In preterm infants, the most common cause of acute respiratory failure is respiratory distress syndro

188 Acute respiratory failure is the most common problem see

189 The incidence of influenza-associated acute respiratory failure is unknown.

190 of noninvasive respiratory support (NRS) in acute respiratory failure, it is likewise likely to also

191 In patients recovering from acute respiratory failure, levels of neurally adjusted v

192 of critically ill patients with COVID-19 and acute respiratory failure, low-dose hydrocortisone, comp

193 dy to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) was an internation

194 dy to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE).

195 Acute respiratory failure, major cardiac complications,

196 CT, organ dysfunction score, cardiac arrest, acute respiratory failure, malignant organ infiltration,

197 ory distress syndrome (ARDS) is a disease of acute respiratory failure manifested by severe hypoxemia

198 ose with complex comorbid diseases including acute respiratory failure may be better treated with IVI

199 Ambulation of patients with acute respiratory failure may be unnecessarily limited i

200 Critically ill patients with acute respiratory failure may benefit from transfer to h

201 eously breathing, nonintubated patients with acute respiratory failure may have a high respiratory dr

202 lated quality of life (HRQL) after pediatric acute respiratory failure.Methods: We assessed functiona

203 ized trial, 2 in 3 children hospitalized for acute respiratory failure missed school after discharge,

204 The majority of patients had acute respiratory failure, multiple organ system failure

205 al face mask included refractory hypercapnic acute respiratory failure (n = 24, 66.7%), painful skin

206 poreal membrane oxygenation in patients with acute respiratory failure; none reported specifically on

207 s of extracorporeal membrane oxygenation for acute respiratory failure of all etiologies, among which

208 noninvasive ventilation outside the ICU for acute respiratory failure of heterogeneous causes and to

209 obstructive pulmonary disease exacerbation, acute respiratory failure of mixed etiologies, and posto

210 en a previously healthy person presents with acute respiratory failure of unknown origin.

211 over two decades; in contrast, patients with acute respiratory failure only experienced marked decrea

212 lead to tissue damage, which can evolve into acute respiratory failure or even death.

213 % CI, 2.12-5.15) compared with patients with acute respiratory failure or multiple organ system failu

214 NG, AND PATIENTS: Critically ill adults with acute respiratory failure or sepsis in ICUs in large aca

215 as independently associated with the risk of acute respiratory failure (OR, 3.54, 95% CI, 1.05-11.96)

216 ilure of mixed etiologies, and postoperative acute respiratory failure) or to prevent acute respirato

217 e average annual incidence of noncardiogenic acute respiratory failure over the entire study period w

218 on of the effects of inhaled nitric oxide in acute respiratory failure patients continues to show tra

219 Transfer of acute respiratory failure patients to the respiratory in

220 In acute respiratory failure patients undergoing pressure s

221 In a cohort of hospitals caring for acute respiratory failure patients, physical therapy/occ

222 generates the hypothesis that in ventilated acute respiratory failure patients, Sigh may enhance reg

223 arch in acute respiratory distress syndrome, acute respiratory failure, pneumonia, and sepsis have yi

224 patients with interstitial lung disease and acute respiratory failure provided they are candidates f

225 ptic shock: 12.6% to 6.7%; septic shock with acute respiratory failure receiving invasive mechanical

226 mechanical ventilation: 20.3% to 11.3%; and acute respiratory failure receiving invasive mechanical

227 ic shock (22.1% to 15.5%), septic shock with acute respiratory failure receiving invasive mechanical

228 mechanical ventilation (28.7% to 22.4%) and acute respiratory failure receiving invasive mechanical

229 0.96) for septic shock, 0.97 (0.97-0.97) for acute respiratory failure receiving invasive mechanical

230 n and septic shock, and 0.99 (0.99-0.99) for acute respiratory failure receiving invasive mechanical

231 shock (21.2% to 10.8%) and septic shock with acute respiratory failure receiving invasive mechanical

232 to 13.4%) but increased among patients with acute respiratory failure receiving invasive mechanical

233 lly ill patients aged 18 years or older with acute respiratory failure receiving mechanical ventilati

234 noncardiogenic pulmonary edema, which causes acute respiratory failure; recovery requires epithelial

235 imated 400,000 patients who annually develop acute respiratory failure, require endotracheal intubati

236 d or older who were admitted to the ICU with acute respiratory failure requiring invasive or noninvas

237 years; women, 55%) admitted to the ICU with acute respiratory failure requiring mechanical ventilati

238 d to plasmablasts appearing in patients with acute respiratory failure requiring mechanical ventilati

239 or equal to 24 months old at follow-up after acute respiratory failure requiring mechanical ventilati

240 Acute respiratory failure requiring mechanical ventilati

241 critically ill patients including those with acute respiratory failure requiring mechanical ventilati

242 al volume loss is common among patients with acute respiratory failure requiring mechanical ventilati

243 The incidence of acute respiratory failure requiring mechanical ventilati

244 metabolites in critically ill children with acute respiratory failure requiring mechanical ventilati

245 health in previously healthy children after acute respiratory failure requiring mechanical ventilati

246 Adult patients (>/= 18 yr old) with acute respiratory failure requiring mechanical ventilati

247 that extracorporeal membrane oxygenation for acute respiratory failure resulting from viral pneumonia

248 Severe H1N1 pneumonia with acute respiratory failure results in infiltration of lun

249 extracorporeal life support for adults with acute respiratory failure reveals an enthusiasm for the

250 on patients who underwent tracheostomy after acute respiratory failure secondary to COVID-19.

251 Managing acute respiratory failure should include appropriate oxy

252 mes in mechanically ventilated patients with acute respiratory failure similar to those of early full

253 Mycophenolate mofetil can cause acute respiratory failure simulating opportunistic infec

254 Among patients hospitalized with acute respiratory failure, SRT compared with usual care

255 dy to Understand the Global Impact of Severe Acute Respiratory Failure) study described the managemen

256 Overall survival of pediatric patients with acute respiratory failure supported by VA or VV ECLS was

257 apy and mobilization goals for patients with acute respiratory failure supported by venovenous extrac

258 acute respiratory distress syndrome (ARDS); acute respiratory failure; surfactant deficiency; saline

259 research studies evaluating the outcomes of acute respiratory failure survivors after hospital disch

260 in all clinical research studies evaluating acute respiratory failure survivors after hospital disch

261 s and 2) results from a qualitative study of acute respiratory failure survivors' outcomes after hosp

262 esults from surveys of clinical researchers, acute respiratory failure survivors, and caregivers that

263 esearch evaluating postdischarge outcomes of acute respiratory failure survivors: clinical researcher

264 ess syndrome (ARDS) is an important cause of acute respiratory failure that is often associated with

265 ible underlying diseases resulting in severe acute respiratory failure that is unresponsive to conven

266 y distress syndrome (ARDS), are syndromes of acute respiratory failure that result from acute pulmona

267 ildren undergoing mechanical ventilation for acute respiratory failure, the use of a sedation protoco

268 ly accepted treatment for some patients with acute respiratory failure, the use of NPPV in patients w

269 nt for at least 2 wks following the onset of acute respiratory failure to insure need for ongoing ven

270 rting the use of noninvasive ventilation for acute respiratory failure to prevent intubation in patie

271 Adult patients with severe acute respiratory failure treated by ECMO from 2000 to 2

272 ough the survival of pediatric patients with acute respiratory failure treated with extracorporeal me

273 Conclusions: In patients with pneumonia with acute respiratory failure treated with HFNC, ROX is an i

274 or intubation was detected in patients with acute respiratory failure treated with high-flow nasal c

275 of immunocompromised patients with hypoxemic acute respiratory failure treated with high-flow nasal o

276 Six (15%) developed acute respiratory failure treated with invasive mechanic

277 In severe acute respiratory failure treated with lung rest and ext

278 patients with interstitial lung disease and acute respiratory failure treated with or without ECMO f

279 ation of his conditions occurred, leading to acute respiratory failure, treated again with steroid pu

280 proved survival, whereas among patients with acute respiratory failure, triage to the ICU compared wi

281 tion on gas exchange in children with severe acute respiratory failure unresponsive to conventional v

282 The incidence of influenza-associated acute respiratory failure was 2.7 per 100,000 person-yea

283 acorporeal membrane oxygenation in pediatric acute respiratory failure was completed in 1993.

284 right ventricular function in patients with acute respiratory failure was determined by assessing th

285 ter assessment of baseline physiologic data, acute respiratory failure was induced by right atrial in

286 ncidence rate ratio for influenza-associated acute respiratory failure was lower among children aged

287 Sepsis, acute kidney injury, and acute respiratory failure were associated with mortality

288 tensive care unit (ICU) for COVID-19-related acute respiratory failure were enrolled from March 7 to

289 eks to 17 years) mechanically ventilated for acute respiratory failure were enrolled in 2009-2013 and

290 , 38 patients with severe H1N1 pneumonia and acute respiratory failure were enrolled.

291 ease referred to our intensive care unit for acute respiratory failure were included in the analysis.

292 aged 1 month to 18 yrs who received ECLS for acute respiratory failure were included.

293 All patients receiving NPPV for acute respiratory failure were screened and enrolled if

294 cember 2004, 50 morbidly obese patients with acute respiratory failure were treated with mechanical v

295 Hyperoxia can exacerbate acute respiratory failure, which has high mortality and

296 physiology score v2 100) with sepsis and/or acute respiratory failure who did not require mechanical

297 trial of 400 ICU patients with sepsis and/or acute respiratory failure, who had two or fewer hospital

298 ty-four patients mechanically ventilated for acute respiratory failure with esophageal balloons place

299 All patients were treated for acute respiratory failure with titrated levels of positi

300 ypothesized that ambulation of patients with acute respiratory failure would increase with transfer t